Mykerafactor

Mykerafactor sells science-backed hair-growth topicals and nutraceuticals centered on a patented keratin-fibroblast growth-factor complex. The line consists of a 2 % topical serum, 5-in-1 growth supplement, and supporting shampoo/conditioner priced between USD 39 and USD 89 per unit, placing the brand in the mid-range trichology segment. All distribution is direct-to-consumer through the company’s own site; no third-party e-tailers or brick-and-mortar stockists are used. The brand’s differentiation is its bio-engineered KeraFactor™ peptide complex that combines 7 growth factors with keratin-stimulating peptides in a nanoliposome carrier, claimed to deliver 96 % follicular penetration. Clinical data posted on the site shows average 24 % density increase after 90 days, and the serum is packaged in airless, UV-blocking pens that meter a 0.25 ml daily dose. Mykerafactor positions itself as a medical-grade yet needle-free alternative to minoxidil and PRP clinics. Core buyers are 25-55-year-old men and women noticing early-stage thinning who want evidence-based results without prescription drugs or office procedures. The audience skews toward health-tech adopters comfortable with subscription auto-ship and willing to photograph scalps under blue-light tracking to monitor progress; sustainability and cruelty-free credentials are secondary to measurable regrowth. Mykerafactor competes against mass-market minoxidil brands, salon-exclusive thickening systems, and telemedicine hair-loss pills. It separates from commodity drugstore options by patenting a peptide-only formula, from salon lines by publishing peer-reviewed efficacy charts, and from prescription startups by avoiding systemic side effects while still offering a subscription model and 150-day money-back guarantee.